Giuseppe B.
- Country
- Italy
- Department
- UOC Oncologia Medica
Research Overview
- Phase III Trial of BI 764532 Plus Carboplatin and Etoposide Versus Carboplatin and Etoposide in Previously Untreated DLL3-Positive Advanced Extrapulmonary Neuroendocrine Carcinoma
- (Peak) A Phase 3 Randomized, Open-label, Multicenter Clinical Study of CGT9486+Sunitinib vs Sunitinib in Subjects with Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
- Phase IIb/III Randomized Controlled Study of Lurbinectedin Plus Doxorubicin Versus Doxorubicin Monotherapy in Metastatic Leiomyosarcoma Patients
Data & Insights
Has run more than one trial at 89 of 183 partner sites.
Specializations
Soft Tissue Sarcomas
Specialized in treating various forms of liposarcoma, particularly focusing on dedifferentiated liposarcoma and leiomyosarcoma. Investigates novel therapeutic approaches for advanced and metastatic manifestations of these conditions.
- Dedifferentiated Liposarcoma Management
- Metastatic Leiomyosarcoma Treatment
- Advanced Soft Tissue Sarcomas
Bone and Connective Tissue Tumors
Expert in treating chondrosarcoma variants, including mesenchymal chondrosarcoma and conventional forms. Also focuses on tenosynovial giant cell tumors and solitary fibrous tumors.
- Conventional Chondrosarcoma Treatment
- Advanced Solitary Fibrous Tumor Therapy
- Mesenchymal Tumor Management
Gastrointestinal Oncology
Specializes in the treatment of gastrointestinal stromal tumors (GIST) and neuroendocrine neoplasias (NENs). Focuses on advanced cases and targeted therapeutic approaches.
- GIST Treatment Strategies
- Neuroendocrine Tumor Management
- Advanced GI Oncology Care
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.